- Bitna Oh
MD, MPH
-
- MD, Family Medicine Board Certified
- Clinical development for TGF-beta inhibitor
- Clinical development for targeted anticancer drugs
- Clinical development for lung, colorectal and urothelial cancer
- Medical Advisor, Global Pharmaceutical Company
- Inyoung Kim
MD, MS
- MD. MS., Internal Medicine, Rheumatology Board Certified
- Ph.D. student, Department of Clinical Research Design and Evaluation, SAIHST (Sep, 2024-)
- Clinical fellow, Division of Rheumatology/University Hospital-Medical Center, Korea
- Subinvestigator/University Hospital, Korea
- Science and Technology Secretary Official/ National Hospital, Korea
- Clinical experiences in cancer, rare, autoimmune, and chronic metabolic diseases
- Regulartory Affairs Professional Course
